COYA (Coya) Bathi saben saham sajroning taun lumaku

The current Coya Therapeutics, Inc. (COYA) share price chart on the GURU.Markets platform reflects EPS dynamics, which stand at -20.70. The business relies on the development of Treg therapy to combat Alzheimer's and ALS. Company growth is driven by clinical trial success rather than macroeconomics. Management, led by Howard Berman, is effectively building partnerships to bring the neuroplatform to market.
COYA (Coya Therapeutics): rincian analitis lan laporan miturut indikator

Coya Therapeutics, Inc. (COYA) is developing an innovative T-cell therapy ecosystem to combat ALS and Alzheimer's disease, a process requiring colossal investments that directly impact profitability. By analyzing the history of EPS YoY (TTM) percentage changes, an investor can observe the growth rates of net income per share, where positive momentum confirms the effectiveness of the business model, while stagnation indicates risks of capital freeze.